Elixabet Bolanos

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

Journal: Cancer research

Published: December 22, 2025

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

Journal: The Journal of experimental medicine

Published: October 08, 2025

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.

Journal: Oncoimmunology

Published: July 11, 2024

Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 09, 2023

Interleukin-18 in cancer immunology and immunotherapy.

Interleukin-18 in cancer immunology and immunotherapy.

Journal: Expert opinion on therapeutic targets

Published: November 22, 2023

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.

Journal: Oncoimmunology

Published: April 10, 2023

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.

Journal: Molecular therapy. Nucleic acids

Published: March 08, 2023

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.

Journal: Molecular therapy. Nucleic acids

Published: January 11, 2023

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.

Journal: Cell reports. Medicine

Published: July 28, 2022

Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.

Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.

Journal: Cancer immunology research

Published: May 07, 2022

Novel strategies exploiting interleukin-12 in cancer immunotherapy.

Novel strategies exploiting interleukin-12 in cancer immunotherapy.

Journal: Pharmacology & therapeutics

Published: January 05, 2022

Advances in mRNA-based drug discovery in cancer immunotherapy.

Advances in mRNA-based drug discovery in cancer immunotherapy.

Journal: Expert opinion on drug discovery

Published: September 09, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026